<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141425">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02156583</url>
  </required_header>
  <id_info>
    <org_study_id>14C.146</org_study_id>
    <nct_id>NCT02156583</nct_id>
  </id_info>
  <brief_title>Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients</brief_title>
  <official_title>Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thoratec Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Skeletal Muscle Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study evaluating changes in frailty and associated impairments in
      older heart failure patients receiving left ventricular assist device therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in frailty following left ventricular assist device implantation</measure>
    <time_frame>Baseline (prior to surgery); 10 days, 1 month, 3 months, and 6 months post-operatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Frailty will be assess based on the domains initially described by Fried and colleagues: weakness, low physical activity, unintentional weight loss, slowness and exhaustion.  Additional frailty measures include the Short Physical Performance Battery (SPPB), as well as gait speed and hand grip strength as single item measures.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle size as measured by ultrasonography</measure>
    <time_frame>Baseline (prior to surgery); 10 days and 3 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Cognitive function measured by the Montreal Cognitive Assessment</measure>
    <time_frame>Baseline; 3 and 6 months post-operatively</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Systolic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Older, left ventricular assist device</arm_group_label>
    <description>Older heart failure patients undergoing left ventricular assist device implantation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive heart failure patients 60 years old or older undergoing left ventricular
        assist device implantation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 years old or older

          -  Scheduled to undergo HeartMate II left ventricular assist device implantation at
             Thomas Jefferson University

        Exclusion Criteria:

          -  Unable or unwilling to provide informed consent

          -  Unable to complete baseline frailty assessment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gordon R Reeves, MD, MPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suzanne Adams, RN, MPH</last_name>
    <phone>215-955-2636</phone>
    <email>suzanne.adams@jefferson.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 3, 2014</lastchanged_date>
  <firstreceived_date>June 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ventricular Assist Device</keyword>
  <keyword>Skeletal Muscle</keyword>
  <keyword>Frailty</keyword>
  <keyword>Older adults</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
